Versant Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Versant Capital Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$264	Buy
2025 Q2	$86	Sell
2025 Q1	$6.53K	Buy
2024 Q4	$7.98K	Buy
2024 Q3	$969	Buy